Staff Writer, Author at CatalystPICR

71 POSTS 0 COMMENTS

SLB ($SLB) Q2 performance beats expectations; EBITDA and cash flow robust

Staff Writer - July 24, 2026 8:13 am

Tesla ($TSLA) Q2 Earnings Miss Expectations; Revenue Surges YoY

Staff Writer - July 22, 2026 5:36 pm

Pfizer’s ($PFE) TALZENNA and XTANDI Combo Accepted for FDA Review

Staff Writer - July 22, 2026 5:11 pm

Alphabet ($GOOGL, $GOOG) Q2 EPS Tops Expectations; YouTube Ads Revenue Climbs

Staff Writer - July 22, 2026 5:10 pm

TE Connectivity ($TEL) Beats Q3 EPS and Revenue Estimates; Expects Strong...

Staff Writer - July 22, 2026 8:35 am

TE Connectivity ($TEL) Beats Q3 EPS and Revenue Estimates; Expects Strong...

Staff Writer - July 22, 2026 8:35 am

Equinor ($EQNR) Q2 Earnings and Revenue Below Forecasts; Dividend Announced

Staff Writer - July 22, 2026 7:45 am

Intuitive Surgical ($ISRG) Q2 Financials Exceed Expectations; Shares Fall in After-Hours...

Staff Writer - July 16, 2026 5:54 pm

Netflix ($NFLX) Reports Q2 Earnings Beat, Revenue Miss; 2026 Outlook Narrowed

Staff Writer - July 16, 2026 5:08 pm

JB Hunt ($JBHT) Q2 EPS and Revenue Outsmart; Stock Up After-Hours

Staff Writer - July 15, 2026 4:43 pm

12 3...8 Page 1 of 8

CATALYST News

Outlook Therapeutics ($OTLK) Secures FDA Approval for LYTENAVA™

NewsDesk - July 24, 2026 3:10 pm

Charter Communications ($CHTR) Beats Q2 EPS Estimates; Revenue Decline Driven by Lower Video Revenue

NewsDesk - July 24, 2026 8:21 am

SLB ($SLB) Q2 performance beats expectations; EBITDA and cash flow robust

Staff Writer - July 24, 2026 8:13 am

Sensient Technologies ($SXT) Beats Q2 EPS and Revenue Estimates; Projects Strong FY26 EPS

NewsDesk - July 24, 2026 8:02 am

American Express ($AXP) Beats EPS Estimates; Revenue Misses Amid Strong YoY Growth

Catalyst Desk - July 24, 2026 8:00 am

American Express ($AXP) Beats EPS Estimates; Revenue Misses Amid Strong YoY Growth

Catalyst Desk - July 24, 2026 8:00 am

FDA Approves MannKind’s ($MNKD) Furoscix ReadyFlow for Heart Failure and CKD

NewsDesk - July 24, 2026 7:25 am

Inhibikase ($IKT) Receives FDA Orphan Drug Designation for IKT-001

Catalyst Desk - July 23, 2026 8:23 am

Tesla ($TSLA) Q2 Earnings Miss Expectations; Revenue Surges YoY

Staff Writer - July 22, 2026 5:36 pm

IBM ($IBM) Exceeds Q2 EPS and Revenue Estimates; Software Revenue Up

NewsDesk - July 22, 2026 5:13 pm